nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—TYMP—Capecitabine—prostate cancer	0.636	0.926	CbGbCtD
Cidofovir—SLC22A6—Conjugated Estrogens—prostate cancer	0.0504	0.0734	CbGbCtD
Cidofovir—TYMP—Pyrimidine metabolism—UMPS—prostate cancer	0.00306	0.085	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—UMPS—prostate cancer	0.00237	0.0659	CbGpPWpGaD
Cidofovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00154	0.0426	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—CYP2A6—prostate cancer	0.00144	0.0399	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—THBS1—prostate cancer	0.00143	0.0396	CbGpPWpGaD
Cidofovir—TYMP—prostate gland—prostate cancer	0.00127	0.264	CbGeAlD
Cidofovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00125	0.0348	CbGpPWpGaD
Cidofovir—TYMP—Pyrimidine metabolism—TYMS—prostate cancer	0.00121	0.0336	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—UMPS—prostate cancer	0.00119	0.0331	CbGpPWpGaD
Cidofovir—TYMP—seminal vesicle—prostate cancer	0.00108	0.223	CbGeAlD
Cidofovir—TYMP—Fluoropyrimidine Activity—TYMS—prostate cancer	0.000937	0.026	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—ERCC2—prostate cancer	0.000871	0.0242	CbGpPWpGaD
Cidofovir—TYMP—urethra—prostate cancer	0.000852	0.177	CbGeAlD
Cidofovir—TYMP—Fluoropyrimidine Activity—MTHFR—prostate cancer	0.000819	0.0227	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—EGF—prostate cancer	0.000715	0.0198	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CDH1—prostate cancer	0.000665	0.0185	CbGpPWpGaD
Cidofovir—TYMP—bone marrow—prostate cancer	0.000655	0.136	CbGeAlD
Cidofovir—TYMP—Bladder Cancer—MAP2K1—prostate cancer	0.00064	0.0178	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—MDM2—prostate cancer	0.000569	0.0158	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—ERBB2—prostate cancer	0.000561	0.0156	CbGpPWpGaD
Cidofovir—TYMP—testis—prostate cancer	0.00056	0.116	CbGeAlD
Cidofovir—TYMP—Bladder Cancer—CXCL8—prostate cancer	0.000532	0.0148	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CCND1—prostate cancer	0.000496	0.0138	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CDKN1A—prostate cancer	0.00048	0.0133	CbGpPWpGaD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000478	0.0133	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—TYMS—prostate cancer	0.000471	0.0131	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—VEGFA—prostate cancer	0.000432	0.012	CbGpPWpGaD
Cidofovir—TYMP—lymph node—prostate cancer	0.000406	0.0842	CbGeAlD
Cidofovir—TYMP—Bladder Cancer—MYC—prostate cancer	0.000398	0.011	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—EGFR—prostate cancer	0.000389	0.0108	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—TP53—prostate cancer	0.000327	0.00907	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—TP53—prostate cancer	0.000311	0.00863	CbGpPWpGaD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000308	0.00854	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000275	0.00762	CbGpPWpGaD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000251	0.00696	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HAO1—prostate cancer	0.000231	0.00642	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000217	0.00602	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GRHL1—prostate cancer	0.000189	0.00523	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CBR1—prostate cancer	0.000189	0.00523	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ADI1—prostate cancer	0.000189	0.00523	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—TST—prostate cancer	0.000189	0.00523	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PSAT1—prostate cancer	0.000189	0.00523	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CSAD—prostate cancer	0.000189	0.00523	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CKMT2—prostate cancer	0.000175	0.00487	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—UGT2B15—prostate cancer	0.000175	0.00487	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GRHPR—prostate cancer	0.000175	0.00487	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—UGT2B17—prostate cancer	0.000175	0.00487	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000172	0.00479	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000172	0.00479	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NAGLU—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SULT2B1—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—RFK—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—AOX1—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTM3—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PGAM2—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—MBTPS1—prostate cancer	0.000165	0.00458	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SRD5A2—prostate cancer	0.000156	0.00434	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NAT1—prostate cancer	0.000156	0.00434	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP3A43—prostate cancer	0.000156	0.00434	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—AMACR—prostate cancer	0.000156	0.00434	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—DEGS1—prostate cancer	0.000156	0.00434	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HSD17B1—prostate cancer	0.000149	0.00414	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.00014	0.00388	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00014	0.00387	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HPGD—prostate cancer	0.000133	0.00369	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—B4GALT4—prostate cancer	0.000133	0.00369	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—TNFRSF21—prostate cancer	0.000125	0.00347	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP7B1—prostate cancer	0.000122	0.00337	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—MTAP—prostate cancer	0.000122	0.00337	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SULT1E1—prostate cancer	0.000118	0.00329	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SRD5A1—prostate cancer	0.000118	0.00329	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000114	0.00316	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HSD17B3—prostate cancer	0.000113	0.00314	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ACSL4—prostate cancer	0.000113	0.00314	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00011	0.00306	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ARG2—prostate cancer	0.000108	0.00301	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—UMPS—prostate cancer	0.000108	0.00301	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PHGDH—prostate cancer	0.000108	0.00301	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—LDHB—prostate cancer	0.000106	0.00295	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP3A5—prostate cancer	0.000104	0.00289	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—TCN2—prostate cancer	0.000101	0.00279	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTA3—prostate cancer	0.000101	0.00279	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PDHA1—prostate cancer	0.000101	0.00279	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—UCP3—prostate cancer	0.000101	0.00279	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC22A3—prostate cancer	9.61e-05	0.00267	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HSD3B1—prostate cancer	9.61e-05	0.00267	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—TBXAS1—prostate cancer	9.21e-05	0.00256	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTA4—prostate cancer	9.21e-05	0.00256	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	8.99e-05	0.0025	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTA2—prostate cancer	8.97e-05	0.00249	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ABCG5—prostate cancer	8.86e-05	0.00246	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SULT1A1—prostate cancer	8.86e-05	0.00246	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	8.76e-05	0.00243	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	8.76e-05	0.00243	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTA1—prostate cancer	8.66e-05	0.0024	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NAT2—prostate cancer	8.56e-05	0.00238	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HSD3B2—prostate cancer	8.56e-05	0.00238	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTO1—prostate cancer	8.56e-05	0.00238	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	8.32e-05	0.00231	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP2C18—prostate cancer	8.21e-05	0.00228	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PLCB2—prostate cancer	8.21e-05	0.00228	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—LRP2—prostate cancer	8.21e-05	0.00228	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—P4HB—prostate cancer	8.05e-05	0.00223	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC22A1—prostate cancer	7.83e-05	0.00217	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SULT2A1—prostate cancer	7.63e-05	0.00212	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—MED12—prostate cancer	7.51e-05	0.00208	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GNG5—prostate cancer	7.45e-05	0.00207	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NCOA3—prostate cancer	7.17e-05	0.00199	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	7.11e-05	0.00197	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HPGDS—prostate cancer	6.84e-05	0.0019	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP2C19—prostate cancer	6.8e-05	0.00189	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTT1—prostate cancer	6.64e-05	0.00184	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ACHE—prostate cancer	6.64e-05	0.00184	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP2A6—prostate cancer	6.56e-05	0.00182	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	6.56e-05	0.00182	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—AKR1C3—prostate cancer	6.38e-05	0.00177	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PRKACB—prostate cancer	6.35e-05	0.00176	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP17A1—prostate cancer	6.28e-05	0.00174	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NCOA2—prostate cancer	5.99e-05	0.00166	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.79e-05	0.00161	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC5A5—prostate cancer	5.71e-05	0.00159	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP2E1—prostate cancer	5.58e-05	0.00155	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NQO1—prostate cancer	5.52e-05	0.00153	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	5.51e-05	0.00153	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—TH—prostate cancer	5.44e-05	0.00151	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP3A4—prostate cancer	5.38e-05	0.00149	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP1B1—prostate cancer	5.29e-05	0.00147	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GGT1—prostate cancer	5.12e-05	0.00142	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NCOA1—prostate cancer	5.05e-05	0.0014	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP19A1—prostate cancer	4.97e-05	0.00138	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—RXRA—prostate cancer	4.8e-05	0.00133	CbGpPWpGaD
Cidofovir—Anorexia—Capecitabine—prostate cancer	4.71e-05	0.000173	CcSEcCtD
Cidofovir—Nausea—Estradiol—prostate cancer	4.71e-05	0.000173	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.7e-05	0.0013	CbGpPWpGaD
Cidofovir—Vomiting—Mitoxantrone—prostate cancer	4.7e-05	0.000172	CcSEcCtD
Cidofovir—Sinusitis—Doxorubicin—prostate cancer	4.69e-05	0.000172	CcSEcCtD
Cidofovir—Convulsion—Prednisone—prostate cancer	4.67e-05	0.000172	CcSEcCtD
Cidofovir—Visual impairment—Epirubicin—prostate cancer	4.67e-05	0.000171	CcSEcCtD
Cidofovir—Hypertension—Prednisone—prostate cancer	4.66e-05	0.000171	CcSEcCtD
Cidofovir—Rash—Mitoxantrone—prostate cancer	4.66e-05	0.000171	CcSEcCtD
Cidofovir—Dermatitis—Mitoxantrone—prostate cancer	4.65e-05	0.000171	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.65e-05	0.000171	CcSEcCtD
Cidofovir—Headache—Mitoxantrone—prostate cancer	4.63e-05	0.00017	CcSEcCtD
Cidofovir—TYMP—Metabolism—COMT—prostate cancer	4.62e-05	0.00128	CbGpPWpGaD
Cidofovir—Hypotension—Capecitabine—prostate cancer	4.62e-05	0.00017	CcSEcCtD
Cidofovir—Insomnia—Docetaxel—prostate cancer	4.62e-05	0.00017	CcSEcCtD
Cidofovir—TYMP—Metabolism—GSTP1—prostate cancer	4.6e-05	0.00128	CbGpPWpGaD
Cidofovir—Arthralgia—Prednisone—prostate cancer	4.59e-05	0.000169	CcSEcCtD
Cidofovir—Myalgia—Prednisone—prostate cancer	4.59e-05	0.000169	CcSEcCtD
Cidofovir—Paraesthesia—Docetaxel—prostate cancer	4.58e-05	0.000168	CcSEcCtD
Cidofovir—Erythema multiforme—Epirubicin—prostate cancer	4.58e-05	0.000168	CcSEcCtD
Cidofovir—Anxiety—Prednisone—prostate cancer	4.58e-05	0.000168	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.56e-05	0.000167	CcSEcCtD
Cidofovir—Dyspnoea—Docetaxel—prostate cancer	4.55e-05	0.000167	CcSEcCtD
Cidofovir—Somnolence—Docetaxel—prostate cancer	4.54e-05	0.000167	CcSEcCtD
Cidofovir—Discomfort—Prednisone—prostate cancer	4.54e-05	0.000167	CcSEcCtD
Cidofovir—Eye disorder—Epirubicin—prostate cancer	4.53e-05	0.000166	CcSEcCtD
Cidofovir—TYMP—Metabolism—ITPR1—prostate cancer	4.53e-05	0.00126	CbGpPWpGaD
Cidofovir—Hypersensitivity—Etoposide—prostate cancer	4.53e-05	0.000166	CcSEcCtD
Cidofovir—Tinnitus—Epirubicin—prostate cancer	4.52e-05	0.000166	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.5e-05	0.000165	CcSEcCtD
Cidofovir—Flushing—Epirubicin—prostate cancer	4.5e-05	0.000165	CcSEcCtD
Cidofovir—Rhinitis—Doxorubicin—prostate cancer	4.5e-05	0.000165	CcSEcCtD
Cidofovir—Dyspepsia—Docetaxel—prostate cancer	4.49e-05	0.000165	CcSEcCtD
Cidofovir—Hepatitis—Doxorubicin—prostate cancer	4.49e-05	0.000165	CcSEcCtD
Cidofovir—Insomnia—Capecitabine—prostate cancer	4.47e-05	0.000164	CcSEcCtD
Cidofovir—Pharyngitis—Doxorubicin—prostate cancer	4.45e-05	0.000163	CcSEcCtD
Cidofovir—Paraesthesia—Capecitabine—prostate cancer	4.44e-05	0.000163	CcSEcCtD
Cidofovir—Decreased appetite—Docetaxel—prostate cancer	4.44e-05	0.000163	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.43e-05	0.00123	CbGpPWpGaD
Cidofovir—Urinary tract disorder—Doxorubicin—prostate cancer	4.43e-05	0.000163	CcSEcCtD
Cidofovir—Oedema peripheral—Doxorubicin—prostate cancer	4.42e-05	0.000162	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Docetaxel—prostate cancer	4.41e-05	0.000162	CcSEcCtD
Cidofovir—Asthenia—Etoposide—prostate cancer	4.41e-05	0.000162	CcSEcCtD
Cidofovir—Dyspnoea—Capecitabine—prostate cancer	4.41e-05	0.000162	CcSEcCtD
Cidofovir—Oedema—Prednisone—prostate cancer	4.4e-05	0.000162	CcSEcCtD
Cidofovir—Anaphylactic shock—Prednisone—prostate cancer	4.4e-05	0.000162	CcSEcCtD
Cidofovir—Angiopathy—Epirubicin—prostate cancer	4.4e-05	0.000161	CcSEcCtD
Cidofovir—Urethral disorder—Doxorubicin—prostate cancer	4.4e-05	0.000161	CcSEcCtD
Cidofovir—Nausea—Mitoxantrone—prostate cancer	4.39e-05	0.000161	CcSEcCtD
Cidofovir—Infection—Prednisone—prostate cancer	4.37e-05	0.000161	CcSEcCtD
Cidofovir—Mediastinal disorder—Epirubicin—prostate cancer	4.37e-05	0.00016	CcSEcCtD
Cidofovir—Pain—Docetaxel—prostate cancer	4.37e-05	0.00016	CcSEcCtD
Cidofovir—Constipation—Docetaxel—prostate cancer	4.37e-05	0.00016	CcSEcCtD
Cidofovir—Dyspepsia—Capecitabine—prostate cancer	4.35e-05	0.00016	CcSEcCtD
Cidofovir—Chills—Epirubicin—prostate cancer	4.35e-05	0.00016	CcSEcCtD
Cidofovir—Pruritus—Etoposide—prostate cancer	4.35e-05	0.00016	CcSEcCtD
Cidofovir—Shock—Prednisone—prostate cancer	4.33e-05	0.000159	CcSEcCtD
Cidofovir—Visual impairment—Doxorubicin—prostate cancer	4.32e-05	0.000159	CcSEcCtD
Cidofovir—Nervous system disorder—Prednisone—prostate cancer	4.32e-05	0.000159	CcSEcCtD
Cidofovir—Tachycardia—Prednisone—prostate cancer	4.3e-05	0.000158	CcSEcCtD
Cidofovir—Decreased appetite—Capecitabine—prostate cancer	4.3e-05	0.000158	CcSEcCtD
Cidofovir—Alopecia—Epirubicin—prostate cancer	4.28e-05	0.000157	CcSEcCtD
Cidofovir—TYMP—Metabolism—TYMS—prostate cancer	4.28e-05	0.00119	CbGpPWpGaD
Cidofovir—Skin disorder—Prednisone—prostate cancer	4.28e-05	0.000157	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Capecitabine—prostate cancer	4.27e-05	0.000157	CcSEcCtD
Cidofovir—Hyperhidrosis—Prednisone—prostate cancer	4.26e-05	0.000156	CcSEcCtD
Cidofovir—Erythema multiforme—Doxorubicin—prostate cancer	4.24e-05	0.000156	CcSEcCtD
Cidofovir—TYMP—Metabolism—GSTM1—prostate cancer	4.23e-05	0.00117	CbGpPWpGaD
Cidofovir—Constipation—Capecitabine—prostate cancer	4.23e-05	0.000155	CcSEcCtD
Cidofovir—Pain—Capecitabine—prostate cancer	4.23e-05	0.000155	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.23e-05	0.00117	CbGpPWpGaD
Cidofovir—Feeling abnormal—Docetaxel—prostate cancer	4.21e-05	0.000154	CcSEcCtD
Cidofovir—Diarrhoea—Etoposide—prostate cancer	4.2e-05	0.000154	CcSEcCtD
Cidofovir—Anorexia—Prednisone—prostate cancer	4.2e-05	0.000154	CcSEcCtD
Cidofovir—Eye disorder—Doxorubicin—prostate cancer	4.19e-05	0.000154	CcSEcCtD
Cidofovir—Tinnitus—Doxorubicin—prostate cancer	4.18e-05	0.000154	CcSEcCtD
Cidofovir—Gastrointestinal pain—Docetaxel—prostate cancer	4.18e-05	0.000153	CcSEcCtD
Cidofovir—Flushing—Doxorubicin—prostate cancer	4.16e-05	0.000153	CcSEcCtD
Cidofovir—Flatulence—Epirubicin—prostate cancer	4.16e-05	0.000153	CcSEcCtD
Cidofovir—TYMP—Metabolism—LPL—prostate cancer	4.15e-05	0.00115	CbGpPWpGaD
Cidofovir—Tension—Epirubicin—prostate cancer	4.14e-05	0.000152	CcSEcCtD
Cidofovir—Dysgeusia—Epirubicin—prostate cancer	4.13e-05	0.000152	CcSEcCtD
Cidofovir—Nervousness—Epirubicin—prostate cancer	4.1e-05	0.00015	CcSEcCtD
Cidofovir—Back pain—Epirubicin—prostate cancer	4.08e-05	0.00015	CcSEcCtD
Cidofovir—Feeling abnormal—Capecitabine—prostate cancer	4.07e-05	0.00015	CcSEcCtD
Cidofovir—Angiopathy—Doxorubicin—prostate cancer	4.07e-05	0.000149	CcSEcCtD
Cidofovir—Dizziness—Etoposide—prostate cancer	4.06e-05	0.000149	CcSEcCtD
Cidofovir—Muscle spasms—Epirubicin—prostate cancer	4.06e-05	0.000149	CcSEcCtD
Cidofovir—Gastrointestinal pain—Capecitabine—prostate cancer	4.04e-05	0.000148	CcSEcCtD
Cidofovir—Mediastinal disorder—Doxorubicin—prostate cancer	4.04e-05	0.000148	CcSEcCtD
Cidofovir—Body temperature increased—Docetaxel—prostate cancer	4.04e-05	0.000148	CcSEcCtD
Cidofovir—Abdominal pain—Docetaxel—prostate cancer	4.04e-05	0.000148	CcSEcCtD
Cidofovir—Chills—Doxorubicin—prostate cancer	4.02e-05	0.000148	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Prednisone—prostate cancer	4.01e-05	0.000147	CcSEcCtD
Cidofovir—TYMP—Metabolism—CYP1A1—prostate cancer	4.01e-05	0.00111	CbGpPWpGaD
Cidofovir—Insomnia—Prednisone—prostate cancer	3.98e-05	0.000146	CcSEcCtD
Cidofovir—TYMP—Metabolism—ERCC2—prostate cancer	3.98e-05	0.0011	CbGpPWpGaD
Cidofovir—Alopecia—Doxorubicin—prostate cancer	3.96e-05	0.000146	CcSEcCtD
Cidofovir—Paraesthesia—Prednisone—prostate cancer	3.95e-05	0.000145	CcSEcCtD
Cidofovir—Urticaria—Capecitabine—prostate cancer	3.93e-05	0.000144	CcSEcCtD
Cidofovir—Ill-defined disorder—Epirubicin—prostate cancer	3.92e-05	0.000144	CcSEcCtD
Cidofovir—Body temperature increased—Capecitabine—prostate cancer	3.91e-05	0.000143	CcSEcCtD
Cidofovir—Abdominal pain—Capecitabine—prostate cancer	3.91e-05	0.000143	CcSEcCtD
Cidofovir—Vomiting—Etoposide—prostate cancer	3.91e-05	0.000143	CcSEcCtD
Cidofovir—Anaemia—Epirubicin—prostate cancer	3.9e-05	0.000143	CcSEcCtD
Cidofovir—Agitation—Epirubicin—prostate cancer	3.88e-05	0.000142	CcSEcCtD
Cidofovir—Dyspepsia—Prednisone—prostate cancer	3.88e-05	0.000142	CcSEcCtD
Cidofovir—Rash—Etoposide—prostate cancer	3.87e-05	0.000142	CcSEcCtD
Cidofovir—Dermatitis—Etoposide—prostate cancer	3.87e-05	0.000142	CcSEcCtD
Cidofovir—Headache—Etoposide—prostate cancer	3.85e-05	0.000141	CcSEcCtD
Cidofovir—Flatulence—Doxorubicin—prostate cancer	3.85e-05	0.000141	CcSEcCtD
Cidofovir—Tension—Doxorubicin—prostate cancer	3.83e-05	0.000141	CcSEcCtD
Cidofovir—Decreased appetite—Prednisone—prostate cancer	3.83e-05	0.000141	CcSEcCtD
Cidofovir—Dysgeusia—Doxorubicin—prostate cancer	3.82e-05	0.00014	CcSEcCtD
Cidofovir—Malaise—Epirubicin—prostate cancer	3.81e-05	0.00014	CcSEcCtD
Cidofovir—Nervousness—Doxorubicin—prostate cancer	3.79e-05	0.000139	CcSEcCtD
Cidofovir—Vertigo—Epirubicin—prostate cancer	3.79e-05	0.000139	CcSEcCtD
Cidofovir—Syncope—Epirubicin—prostate cancer	3.78e-05	0.000139	CcSEcCtD
Cidofovir—Leukopenia—Epirubicin—prostate cancer	3.78e-05	0.000139	CcSEcCtD
Cidofovir—Back pain—Doxorubicin—prostate cancer	3.78e-05	0.000139	CcSEcCtD
Cidofovir—Constipation—Prednisone—prostate cancer	3.77e-05	0.000138	CcSEcCtD
Cidofovir—Hypersensitivity—Docetaxel—prostate cancer	3.76e-05	0.000138	CcSEcCtD
Cidofovir—Muscle spasms—Doxorubicin—prostate cancer	3.75e-05	0.000138	CcSEcCtD
Cidofovir—TYMP—Metabolism—MTHFR—prostate cancer	3.74e-05	0.00104	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.73e-05	0.00104	CbGpPWpGaD
Cidofovir—Loss of consciousness—Epirubicin—prostate cancer	3.71e-05	0.000136	CcSEcCtD
Cidofovir—Cough—Epirubicin—prostate cancer	3.68e-05	0.000135	CcSEcCtD
Cidofovir—TYMP—Metabolism—PPARA—prostate cancer	3.67e-05	0.00102	CbGpPWpGaD
Cidofovir—Asthenia—Docetaxel—prostate cancer	3.66e-05	0.000134	CcSEcCtD
Cidofovir—Convulsion—Epirubicin—prostate cancer	3.66e-05	0.000134	CcSEcCtD
Cidofovir—Nausea—Etoposide—prostate cancer	3.65e-05	0.000134	CcSEcCtD
Cidofovir—Hypertension—Epirubicin—prostate cancer	3.64e-05	0.000134	CcSEcCtD
Cidofovir—Hypersensitivity—Capecitabine—prostate cancer	3.64e-05	0.000134	CcSEcCtD
Cidofovir—Feeling abnormal—Prednisone—prostate cancer	3.63e-05	0.000133	CcSEcCtD
Cidofovir—Ill-defined disorder—Doxorubicin—prostate cancer	3.62e-05	0.000133	CcSEcCtD
Cidofovir—Pruritus—Docetaxel—prostate cancer	3.61e-05	0.000133	CcSEcCtD
Cidofovir—Anaemia—Doxorubicin—prostate cancer	3.61e-05	0.000132	CcSEcCtD
Cidofovir—Gastrointestinal pain—Prednisone—prostate cancer	3.6e-05	0.000132	CcSEcCtD
Cidofovir—Myalgia—Epirubicin—prostate cancer	3.59e-05	0.000132	CcSEcCtD
Cidofovir—Arthralgia—Epirubicin—prostate cancer	3.59e-05	0.000132	CcSEcCtD
Cidofovir—Chest pain—Epirubicin—prostate cancer	3.59e-05	0.000132	CcSEcCtD
Cidofovir—Agitation—Doxorubicin—prostate cancer	3.59e-05	0.000132	CcSEcCtD
Cidofovir—Anxiety—Epirubicin—prostate cancer	3.58e-05	0.000131	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.57e-05	0.000131	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	3.55e-05	0.000986	CbGpPWpGaD
Cidofovir—Discomfort—Epirubicin—prostate cancer	3.55e-05	0.00013	CcSEcCtD
Cidofovir—Asthenia—Capecitabine—prostate cancer	3.55e-05	0.00013	CcSEcCtD
Cidofovir—Malaise—Doxorubicin—prostate cancer	3.52e-05	0.000129	CcSEcCtD
Cidofovir—Dry mouth—Epirubicin—prostate cancer	3.51e-05	0.000129	CcSEcCtD
Cidofovir—Vertigo—Doxorubicin—prostate cancer	3.51e-05	0.000129	CcSEcCtD
Cidofovir—Syncope—Doxorubicin—prostate cancer	3.5e-05	0.000129	CcSEcCtD
Cidofovir—Urticaria—Prednisone—prostate cancer	3.5e-05	0.000128	CcSEcCtD
Cidofovir—Pruritus—Capecitabine—prostate cancer	3.5e-05	0.000128	CcSEcCtD
Cidofovir—Leukopenia—Doxorubicin—prostate cancer	3.5e-05	0.000128	CcSEcCtD
Cidofovir—Diarrhoea—Docetaxel—prostate cancer	3.49e-05	0.000128	CcSEcCtD
Cidofovir—Body temperature increased—Prednisone—prostate cancer	3.48e-05	0.000128	CcSEcCtD
Cidofovir—Abdominal pain—Prednisone—prostate cancer	3.48e-05	0.000128	CcSEcCtD
Cidofovir—Confusional state—Epirubicin—prostate cancer	3.47e-05	0.000127	CcSEcCtD
Cidofovir—TYMP—Metabolism—CAV1—prostate cancer	3.45e-05	0.000957	CbGpPWpGaD
Cidofovir—Anaphylactic shock—Epirubicin—prostate cancer	3.44e-05	0.000126	CcSEcCtD
Cidofovir—Oedema—Epirubicin—prostate cancer	3.44e-05	0.000126	CcSEcCtD
Cidofovir—Loss of consciousness—Doxorubicin—prostate cancer	3.43e-05	0.000126	CcSEcCtD
Cidofovir—Infection—Epirubicin—prostate cancer	3.42e-05	0.000126	CcSEcCtD
Cidofovir—Cough—Doxorubicin—prostate cancer	3.41e-05	0.000125	CcSEcCtD
Cidofovir—Shock—Epirubicin—prostate cancer	3.39e-05	0.000124	CcSEcCtD
Cidofovir—Convulsion—Doxorubicin—prostate cancer	3.38e-05	0.000124	CcSEcCtD
Cidofovir—Diarrhoea—Capecitabine—prostate cancer	3.38e-05	0.000124	CcSEcCtD
Cidofovir—Nervous system disorder—Epirubicin—prostate cancer	3.38e-05	0.000124	CcSEcCtD
Cidofovir—Dizziness—Docetaxel—prostate cancer	3.38e-05	0.000124	CcSEcCtD
Cidofovir—Thrombocytopenia—Epirubicin—prostate cancer	3.37e-05	0.000124	CcSEcCtD
Cidofovir—Hypertension—Doxorubicin—prostate cancer	3.37e-05	0.000124	CcSEcCtD
Cidofovir—Tachycardia—Epirubicin—prostate cancer	3.36e-05	0.000123	CcSEcCtD
Cidofovir—Skin disorder—Epirubicin—prostate cancer	3.35e-05	0.000123	CcSEcCtD
Cidofovir—Hyperhidrosis—Epirubicin—prostate cancer	3.33e-05	0.000122	CcSEcCtD
Cidofovir—Arthralgia—Doxorubicin—prostate cancer	3.32e-05	0.000122	CcSEcCtD
Cidofovir—Myalgia—Doxorubicin—prostate cancer	3.32e-05	0.000122	CcSEcCtD
Cidofovir—Chest pain—Doxorubicin—prostate cancer	3.32e-05	0.000122	CcSEcCtD
Cidofovir—Anxiety—Doxorubicin—prostate cancer	3.31e-05	0.000122	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.3e-05	0.000121	CcSEcCtD
Cidofovir—Discomfort—Doxorubicin—prostate cancer	3.28e-05	0.000121	CcSEcCtD
Cidofovir—Anorexia—Epirubicin—prostate cancer	3.28e-05	0.000121	CcSEcCtD
Cidofovir—Dizziness—Capecitabine—prostate cancer	3.27e-05	0.00012	CcSEcCtD
Cidofovir—Dry mouth—Doxorubicin—prostate cancer	3.25e-05	0.000119	CcSEcCtD
Cidofovir—Vomiting—Docetaxel—prostate cancer	3.25e-05	0.000119	CcSEcCtD
Cidofovir—Hypersensitivity—Prednisone—prostate cancer	3.24e-05	0.000119	CcSEcCtD
Cidofovir—Rash—Docetaxel—prostate cancer	3.22e-05	0.000118	CcSEcCtD
Cidofovir—Hypotension—Epirubicin—prostate cancer	3.22e-05	0.000118	CcSEcCtD
Cidofovir—Dermatitis—Docetaxel—prostate cancer	3.22e-05	0.000118	CcSEcCtD
Cidofovir—Confusional state—Doxorubicin—prostate cancer	3.21e-05	0.000118	CcSEcCtD
Cidofovir—Headache—Docetaxel—prostate cancer	3.2e-05	0.000117	CcSEcCtD
Cidofovir—Anaphylactic shock—Doxorubicin—prostate cancer	3.19e-05	0.000117	CcSEcCtD
Cidofovir—Oedema—Doxorubicin—prostate cancer	3.19e-05	0.000117	CcSEcCtD
Cidofovir—Infection—Doxorubicin—prostate cancer	3.17e-05	0.000116	CcSEcCtD
Cidofovir—Asthenia—Prednisone—prostate cancer	3.16e-05	0.000116	CcSEcCtD
Cidofovir—Vomiting—Capecitabine—prostate cancer	3.14e-05	0.000115	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CG—prostate cancer	3.14e-05	0.000872	CbGpPWpGaD
Cidofovir—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.14e-05	0.000115	CcSEcCtD
Cidofovir—Shock—Doxorubicin—prostate cancer	3.14e-05	0.000115	CcSEcCtD
Cidofovir—Nervous system disorder—Doxorubicin—prostate cancer	3.13e-05	0.000115	CcSEcCtD
Cidofovir—Thrombocytopenia—Doxorubicin—prostate cancer	3.12e-05	0.000115	CcSEcCtD
Cidofovir—Rash—Capecitabine—prostate cancer	3.12e-05	0.000114	CcSEcCtD
Cidofovir—Pruritus—Prednisone—prostate cancer	3.12e-05	0.000114	CcSEcCtD
Cidofovir—Insomnia—Epirubicin—prostate cancer	3.11e-05	0.000114	CcSEcCtD
Cidofovir—Dermatitis—Capecitabine—prostate cancer	3.11e-05	0.000114	CcSEcCtD
Cidofovir—Tachycardia—Doxorubicin—prostate cancer	3.11e-05	0.000114	CcSEcCtD
Cidofovir—Headache—Capecitabine—prostate cancer	3.1e-05	0.000114	CcSEcCtD
Cidofovir—Skin disorder—Doxorubicin—prostate cancer	3.1e-05	0.000114	CcSEcCtD
Cidofovir—Paraesthesia—Epirubicin—prostate cancer	3.09e-05	0.000114	CcSEcCtD
Cidofovir—Hyperhidrosis—Doxorubicin—prostate cancer	3.08e-05	0.000113	CcSEcCtD
Cidofovir—Dyspnoea—Epirubicin—prostate cancer	3.07e-05	0.000113	CcSEcCtD
Cidofovir—Somnolence—Epirubicin—prostate cancer	3.06e-05	0.000112	CcSEcCtD
Cidofovir—Anorexia—Doxorubicin—prostate cancer	3.04e-05	0.000112	CcSEcCtD
Cidofovir—Nausea—Docetaxel—prostate cancer	3.03e-05	0.000111	CcSEcCtD
Cidofovir—Dyspepsia—Epirubicin—prostate cancer	3.03e-05	0.000111	CcSEcCtD
Cidofovir—Diarrhoea—Prednisone—prostate cancer	3.01e-05	0.000111	CcSEcCtD
Cidofovir—Decreased appetite—Epirubicin—prostate cancer	2.99e-05	0.00011	CcSEcCtD
Cidofovir—Hypotension—Doxorubicin—prostate cancer	2.98e-05	0.000109	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Epirubicin—prostate cancer	2.97e-05	0.000109	CcSEcCtD
Cidofovir—TYMP—Metabolism—INS—prostate cancer	2.97e-05	0.000825	CbGpPWpGaD
Cidofovir—Pain—Epirubicin—prostate cancer	2.95e-05	0.000108	CcSEcCtD
Cidofovir—Constipation—Epirubicin—prostate cancer	2.95e-05	0.000108	CcSEcCtD
Cidofovir—Nausea—Capecitabine—prostate cancer	2.94e-05	0.000108	CcSEcCtD
Cidofovir—Dizziness—Prednisone—prostate cancer	2.91e-05	0.000107	CcSEcCtD
Cidofovir—TYMP—Metabolism—CREBBP—prostate cancer	2.91e-05	0.000808	CbGpPWpGaD
Cidofovir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.9e-05	0.000107	CcSEcCtD
Cidofovir—Insomnia—Doxorubicin—prostate cancer	2.88e-05	0.000106	CcSEcCtD
Cidofovir—Paraesthesia—Doxorubicin—prostate cancer	2.86e-05	0.000105	CcSEcCtD
Cidofovir—Dyspnoea—Doxorubicin—prostate cancer	2.84e-05	0.000104	CcSEcCtD
Cidofovir—Feeling abnormal—Epirubicin—prostate cancer	2.84e-05	0.000104	CcSEcCtD
Cidofovir—Somnolence—Doxorubicin—prostate cancer	2.83e-05	0.000104	CcSEcCtD
Cidofovir—Gastrointestinal pain—Epirubicin—prostate cancer	2.82e-05	0.000103	CcSEcCtD
Cidofovir—Dyspepsia—Doxorubicin—prostate cancer	2.81e-05	0.000103	CcSEcCtD
Cidofovir—Vomiting—Prednisone—prostate cancer	2.8e-05	0.000103	CcSEcCtD
Cidofovir—Rash—Prednisone—prostate cancer	2.78e-05	0.000102	CcSEcCtD
Cidofovir—Dermatitis—Prednisone—prostate cancer	2.77e-05	0.000102	CcSEcCtD
Cidofovir—Decreased appetite—Doxorubicin—prostate cancer	2.77e-05	0.000102	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CD—prostate cancer	2.76e-05	0.000766	CbGpPWpGaD
Cidofovir—Headache—Prednisone—prostate cancer	2.76e-05	0.000101	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.75e-05	0.000101	CcSEcCtD
Cidofovir—Urticaria—Epirubicin—prostate cancer	2.74e-05	0.0001	CcSEcCtD
Cidofovir—Constipation—Doxorubicin—prostate cancer	2.73e-05	0.0001	CcSEcCtD
Cidofovir—Pain—Doxorubicin—prostate cancer	2.73e-05	0.0001	CcSEcCtD
Cidofovir—Abdominal pain—Epirubicin—prostate cancer	2.72e-05	9.99e-05	CcSEcCtD
Cidofovir—Body temperature increased—Epirubicin—prostate cancer	2.72e-05	9.99e-05	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	2.71e-05	0.000753	CbGpPWpGaD
Cidofovir—Feeling abnormal—Doxorubicin—prostate cancer	2.63e-05	9.64e-05	CcSEcCtD
Cidofovir—Nausea—Prednisone—prostate cancer	2.62e-05	9.6e-05	CcSEcCtD
Cidofovir—TYMP—Metabolism—NOS3—prostate cancer	2.61e-05	0.000723	CbGpPWpGaD
Cidofovir—Gastrointestinal pain—Doxorubicin—prostate cancer	2.61e-05	9.57e-05	CcSEcCtD
Cidofovir—Hypersensitivity—Epirubicin—prostate cancer	2.54e-05	9.32e-05	CcSEcCtD
Cidofovir—Urticaria—Doxorubicin—prostate cancer	2.53e-05	9.29e-05	CcSEcCtD
Cidofovir—Body temperature increased—Doxorubicin—prostate cancer	2.52e-05	9.25e-05	CcSEcCtD
Cidofovir—Abdominal pain—Doxorubicin—prostate cancer	2.52e-05	9.25e-05	CcSEcCtD
Cidofovir—Asthenia—Epirubicin—prostate cancer	2.47e-05	9.07e-05	CcSEcCtD
Cidofovir—Pruritus—Epirubicin—prostate cancer	2.44e-05	8.95e-05	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CB—prostate cancer	2.41e-05	0.000668	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PTGS2—prostate cancer	2.38e-05	0.000662	CbGpPWpGaD
Cidofovir—Diarrhoea—Epirubicin—prostate cancer	2.36e-05	8.65e-05	CcSEcCtD
Cidofovir—Hypersensitivity—Doxorubicin—prostate cancer	2.35e-05	8.62e-05	CcSEcCtD
Cidofovir—Asthenia—Doxorubicin—prostate cancer	2.29e-05	8.39e-05	CcSEcCtD
Cidofovir—Dizziness—Epirubicin—prostate cancer	2.28e-05	8.36e-05	CcSEcCtD
Cidofovir—Pruritus—Doxorubicin—prostate cancer	2.25e-05	8.28e-05	CcSEcCtD
Cidofovir—Vomiting—Epirubicin—prostate cancer	2.19e-05	8.04e-05	CcSEcCtD
Cidofovir—Diarrhoea—Doxorubicin—prostate cancer	2.18e-05	8e-05	CcSEcCtD
Cidofovir—Rash—Epirubicin—prostate cancer	2.17e-05	7.97e-05	CcSEcCtD
Cidofovir—Dermatitis—Epirubicin—prostate cancer	2.17e-05	7.96e-05	CcSEcCtD
Cidofovir—Headache—Epirubicin—prostate cancer	2.16e-05	7.92e-05	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.15e-05	0.000598	CbGpPWpGaD
Cidofovir—Dizziness—Doxorubicin—prostate cancer	2.11e-05	7.74e-05	CcSEcCtD
Cidofovir—TYMP—Metabolism—PTEN—prostate cancer	2.08e-05	0.000577	CbGpPWpGaD
Cidofovir—Nausea—Epirubicin—prostate cancer	2.05e-05	7.51e-05	CcSEcCtD
Cidofovir—Vomiting—Doxorubicin—prostate cancer	2.03e-05	7.44e-05	CcSEcCtD
Cidofovir—Rash—Doxorubicin—prostate cancer	2.01e-05	7.38e-05	CcSEcCtD
Cidofovir—Dermatitis—Doxorubicin—prostate cancer	2.01e-05	7.37e-05	CcSEcCtD
Cidofovir—Headache—Doxorubicin—prostate cancer	2e-05	7.33e-05	CcSEcCtD
Cidofovir—TYMP—Metabolism—EP300—prostate cancer	1.98e-05	0.00055	CbGpPWpGaD
Cidofovir—Nausea—Doxorubicin—prostate cancer	1.89e-05	6.95e-05	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CA—prostate cancer	1.47e-05	0.000407	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—AKT1—prostate cancer	1.2e-05	0.000333	CbGpPWpGaD
